2.48
前日終値:
$2.55
開ける:
$2.57
24時間の取引高:
560.30K
Relative Volume:
1.37
時価総額:
$156.49M
収益:
$233.00K
当期純損益:
$-64.61M
株価収益率:
-2.1498
EPS:
-1.1536
ネットキャッシュフロー:
$-58.32M
1週間 パフォーマンス:
+16.05%
1か月 パフォーマンス:
+4.83%
6か月 パフォーマンス:
-12.15%
1年 パフォーマンス:
+21.71%
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
名前
Connect Biopharma Holdings Ltd
セクター
電話
858-727-1040
住所
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CNTB
Connect Biopharma Holdings Ltd
|
2.485 | 160.58M | 233.00K | -64.61M | -58.32M | -1.1536 |
|
VRTX
Vertex Pharmaceuticals Inc
|
515.57 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
805.86 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
986.80 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
211.94 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
362.66 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-01 | 開始されました | Lake Street | Buy |
| 2025-10-31 | 開始されました | BTIG Research | Buy |
| 2025-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-13 | 開始されました | Jefferies | Buy |
| 2021-04-13 | 開始されました | Piper Sandler | Overweight |
| 2021-04-13 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Connect Biopharma Holdings Ltd (CNTB) 最新ニュース
Connect Biopharma Holdings Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
HC Wainwright Issues Pessimistic Forecast for CNTB Earnings - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Ikarian Capital (CNTB) discloses 6.9% Connect Biopharma holding on Schedule 13G/A - Stock Titan
Connect Biopharma (CNTB) investor Wei Zheng discloses 4% beneficial stake - Stock Titan
Connect Biopharma Holdings Ltd expected to post a loss of 21 cents a shareEarnings Preview - TradingView
H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Connect Biopharma Holdings earnings beat by ¥0.34, revenue topped estimates - Investing.com Canada
Connect Biopharma Q2 Results: Net Loss Widens To $17.3 Million - scanx.trade
Connect Biopharma (NASDAQ:CNTB) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Connect Biopharma (CNTB) ramps rademikibart spend as losses deepen in 2026 - Stock Titan
Connect Biopharma Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Connect Biopharma (CNTB) widens Q2 2026 loss as R&D rises, cash at $31.5M - Stock Titan
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Connect Biopharma Holdings Ltd (CNTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Holdings Ltd (CNTB) Stock News Today - TradingKey
Connect Biopharma (CNTB) Projected to Release Earnings on Wednesday - MarketBeat
CNTB|Connect Biopharma Holdings Ltd|Price:2.020|Chg%:-0.070 - TradingKey
ADAR1 Capital Management LLC Invests $1.95 Million in Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
Connect Biopharma Holdings Ltd (CNTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CNTB|Connect Biopharma Holdings Ltd|Price:2.110|Chg%:-0.030 - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Balance Sheet - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Income Statement - TradingKey
CNTB|Connect Biopharma Holdings Ltd|Price:2.140|Chg%:-0.060 - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BIO 2026: Catching Up With Vaxart, Aphaia, Connect Biopharma, Kyverna And Chugai - insights.citeline.com
Lake Street Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Oppenheimer Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $8 - Moomoo
CNTB Initiates Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
Oppenheimer initiates Connect Biopharma stock with outperform rating By Investing.com - Investing.com Nigeria
Oppenheimer initiates Connect Biopharma stock with outperform rating - Investing.com
CNTB Stock Price, Quote & Chart - ChartMill
CNTBConnect Biopharma Holdings Ltd Dividends - Finviz
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - MPNnow.com
Form 4 Connect Biopharma Holdings Ltd For: 1 July By Investing.com - Investing.com Canada
Connect Biopharma (CNTB) director granted 3,738 fully vested shares as fees - Stock Titan
Connect Biopharma (NASDAQ: CNTB) director receives 6,718-share award as 2026 board compensation - Stock Titan
CCORF Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell 2000 Index - marketscreener.com
Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell Microcap Index - marketscreener.com
Piper Sandler initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com Nigeria
Piper Sandler initiates Connect Biopharma stock with overweight rating - Investing.com
Connect Biopharma Holdings Ltd. Actuals & Estimates (NASDAQ:CNTB) - TradingView
H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7 - Investing.com
Analysts’ Top Healthcare Picks: Diamedica Therapeutics (DMAC), Guardian Pharmacy Services, Inc. Class A (GRDN) - The Globe and Mail
Connect Biopharma Holdings Ltd (CNTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CNTB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Connect Biopharma Holdings Ltd (CNTB) 財務データ
収益
当期純利益
現金流量
EPS
Connect Biopharma Holdings Ltd (CNTB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Huang James | Director |
Mar 31 '26 |
Buy |
3.45 |
1,160,000 |
4,002,000 |
13,160,000 |
大文字化:
|
ボリューム (24 時間):